(Q24246399)

1

0 references

José M Ferro

2

0 references

Jordi Matias-Guiu

3

0 references

Jose Alvarez-Sabin

Cochrane Database of Systematic Reviews

4

0 references

language of work or name

English

0 references

publication date

20 July 2005

0 references

published in

0 references

issue

3

0 references

page(s)

CD004296

0 references

cites work

Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Meta-analysis, Simpson's paradox, and the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Outcome of patients with diabetes and unstable angina. A subgroup analysis in the Spanish Multicentre Trial of trifusal in unstable angina. Grupo de Estudio del Trifusal en la Angina Inestable

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021

Antiplatelet Agents and Their Effect on Complications during or Soon after Percutaneous Transluminal Coronary Angioplasty

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004296.PUB2

7 January 2021